M.A., economics and B.Sc., mathematics, Université Laval
Summary of Experience
Mr. Lefebvre specializes in the application of biostatistics and economics of health outcomes research. He has conducted and directed numerous studies in pharmacoeconomics, epidemiology, and health outcomes research in a variety of therapeutic areas such as anemia, asthma, cardiovascular diseases, chronic obstructive pulmonary disease, diabetes, genetic syndrome, hematology, hypertension, infectious diseases, myelodysplastic syndromes, neurological disorders, obesity, oncology, renal diseases, respiratory diseases, and women's health. His recent work in the health care sector includes numerous clinical trials and medical claims data analyses to investigate resource utilization patterns, patient-reported quality of life, clinical effectiveness, direct medical and indirect productivity costs of a disease burden, and cost-effectiveness associated with the use of pharmaceuticals. His extensive research is reflected in over 100 peer-reviewed publications in prominent clinical and health economics journals. Mr. Lefebvre's scientific research has also resulted in numerous presentations at health care conferences as well as presentations to the U.S. Food and Drug Administration and Centers for Medicare & Medicaid Services, and has included several high-profile studies publicized in the media, including a recent article on the economic burden of vasomotor symptoms in post-menopausal women cited in The Wall Street Journal blog Pharmalot. He has served as a peer reviewer for several journals, including CHEST, Annals of Oncology, Acta Oncologica, Clinical Journal of the American Society of Nephrology, Allergy & Asthma Proceedings, Journal of Managed Care Pharmacy, American Journal of Managed Care, PLOS ONE, Value in Health, PharmacoEconomics, Current Medical Research Opinion, and Journal of Medical Economics. Mr. Lefebvre is a member of the International Society of Pharmacoepidemiology and the International Society of Pharmacoeconomics and Outcomes Research.
Read Patrick's profile